CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

The CliniMACS CD34 Reagent System is used to separate CD34 cells from the remaining stem cell product, using a peripheral blood stem cell sample provided by the original donor. These CD34 cells are then infused into the recipient following selection with the intent to restore function of the blood forming cells.

The selected CD34 cells separated by the CliniMACS CD34 Reagent System are infused into the recipient.